|1.||Mittal, Neelam: 1 article (09/2006)|
|2.||Pandit, J K: 1 article (09/2006)|
|3.||Ridhurkar, D: 1 article (09/2006)|
|4.||Barat, Romi: 1 article (09/2006)|
|5.||Balasubramaniam, J: 1 article (09/2006)|
|6.||Mishra, Deena Nath: 1 article (09/2006)|
|7.||Srinatha, A: 1 article (09/2006)|
|8.||Yadav, S: 1 article (10/2001)|
|9.||Grover, J K: 1 article (10/2001)|
|10.||Vats, V: 1 article (10/2001)|
03/01/1967 - "[Possibilities of protection against schistosoma in bilharziasis patients, previously treated with Ambilhar]."
09/01/1973 - "A study of the effects of weekly doses of niridazole on schistosome egg output and miricidial hatching in a patient suffering from bilharziasis."
11/01/1968 - "Trial with ambilhar in the treatment of bilharziasis in Iraq."
07/27/1968 - "Further trials of niridazole in urinary tract bilharziasis."
05/01/1966 - "[Study of the action of Ciba 32644 BA (Ambilhar) in urinary bilharziasis. "
06/01/1992 - "Niridazole-treated mice were free of any foci 10 days after the last treatment and no adult worms were recovered on perfusion of the hepatic portal system relative to control mice from which 5.8% of the infective cercariae were recovered as adult worms at Day 42 post-infection."
07/01/1984 - "Niridazole and six of its metabolites have been quantitated by high-pressure liquid chromatography in sera of four male Filipino patients with mild Schistosoma japonicum infections given single oral doses of niridazole (15 mg/kg) on two occasions 10 days apart. "
07/01/1984 - "Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection."
01/01/1982 - "typhimurium was not found, as demonstrated by infection with a niridazole-resistant strain of S. "
01/01/1982 - "A suppressive effect of niridazole treatment on immunity to challenge infection with S. "
|3.||Schistosomiasis haematobia (Schistosomiasis haematobium)
10/06/1969 - "Efficacy of niridazole in schistosomiasis haematobium."
10/01/1986 - "Influence of the dosing interval on the response of urinary schistosomiasis to therapy with niridazole."
07/01/1986 - "The side-effects of niridazole used for urinary schistosomiasis were studied prospectively over a 3-month period in male patients receiving the standard dose of 25 mg day-1 kg-1 for 7 days. "
05/01/1981 - "I.) investigations in the post-therapeutical course of the urinary schistosomiasis was carried out in a group of 25 patients treated with niridazole and on a group of 25 patients treated with 35 972 RP. "
10/06/1969 - "Activity of niridazole in urinary schistosomiasis: prophylaxis and principles of control."
|4.||Delayed Hypersensitivity (Hypersensitivity, Type IV)
12/01/1979 - "Niridazole was found to be more potent with respect to suppression of cutaneous delayed hypersensitivity in the former than in the latter. "
10/01/1984 - "The antischistosomal drug niridazole has been shown to inhibit inductive (Vadas and Bernard, 1981) as well as effector phases of delayed hypersensitivity (Sainis et al., 1983). "
06/01/1983 - "Modulation of delayed hypersensitivity to sheep erythrocytes by niridazole."
12/01/1979 - "This component was found to be chromatographically pure; have a simple UV absorbance spectrum containing no 360 nm absorbing material characteristic of niridazole; to show no strain difference with respect to potency or efficacy in the ear-swelling assay for cutaneous delayed hypersensitivity; and to be 10(7) times more potent than niridazole with respect to the suppression of cutaneous delayed hypersensitivity."
12/01/1979 - "Effect of niridazole and niridazole immunoregulatory factor (NIF) on cutaneous delayed hypersensitivity in mice."
|5.||Amebic Dysentery (Amoebic Dysentery)
10/06/1969 - "Efficacy of niridazole in amoebic dysentery."
08/16/1970 - "Niridazole in amoebic dysentery."
10/01/1968 - "Ambilhar in amebic dysentery and hepatic amebiasis."
09/01/1968 - "Niridazole in amebic dysentery and hepatic amebiasis."
07/02/1966 - "Ambilhar in amoebic dysentery and amoebic liver abscess."
|4.||Lysophospholipase (Phospholipase B)
|5.||Antilymphocyte Serum (Anti-Thymocyte Globulin)
|1.||Drug Therapy (Chemotherapy)
|3.||Homologous Transplantation (Allograft)